This company's short life on the stock market has been a constant challenge.In today's uncertain economic environment, investing in robust dividend stocks can be a great hedge. Companies that can consistently issue growing payouts tend to have strong underlying businesses capable of surviving economic conditions that keep changing. It's even better to scoop up shares of companies that fit that profile while they trade at a significant discount.Take Kenvue (KVUE 4.70%), for example. It's a relatively new com ...

Key Points The stock market, and individual stocks, can be volatile over short periods. A bunch of these value-shedding stocks have posted disappointing quarterly results. Some fallen stocks can present great opportunities. 10 stocks we like better than CarMax › It's fun to follow stocks that soared recently, and it can be sobering to see which ones have plunged -- especially if you're a shareholder. So here's a look at the worst-performing stocks in the S&P 500 index of 500 of America's biggest ...

Kenvue (KVUE) faces significant regulatory and reputational headwinds as the Trump administration asserted, without evidence, a definitive link between acetaminophen, the active ingredient in pain reliever Tylenol, and autism during pregnancy. This represents a direct challenge to one of Kenvue's most important revenue drivers within its Self-Care segment, which includes trusted brands such as Tylenol, Motrin, and Benadryl. The consumer health company, spun off from Johnson & Johnson (JNJ) in 2023, has re ...